OptimizeRx Corporation (OPRX)
NASDAQ: OPRX · Real-Time Price · USD
8.65
+0.27 (3.22%)
Apr 25, 2025, 4:00 PM EDT - Market closed
OptimizeRx Market Cap
OptimizeRx has a market cap or net worth of $160.13 million as of April 25, 2025. Its market cap has decreased by -19.45% in one year.
Market Cap
160.13M
Enterprise Value
179.94M
1-Year Change
-19.45%
Ranking
Category
Stock Price
$8.65
Market Cap Chart
Since June 22, 2018, OptimizeRx's market cap has increased from $34.20M to $160.13M, an increase of 368.21%. That is a compound annual growth rate of 25.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 25, 2025 | 160.10M | 78.88% |
| Dec 31, 2024 | 89.50M | -65.55% |
| Dec 29, 2023 | 259.80M | -9.85% |
| Dec 30, 2022 | 288.20M | -73.89% |
| Dec 31, 2021 | 1.10B | 134.43% |
| Dec 31, 2020 | 470.80M | 223.35% |
| Dec 31, 2019 | 145.60M | 10.47% |
| Dec 31, 2018 | 131.80M | 285.38% |
View and export this data all the way back to 2018.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Eli Lilly and Company | 794.31B |
| UnitedHealth Group | 381.06B |
| Johnson & Johnson | 371.93B |
| AbbVie | 329.14B |
| Novo Nordisk | 272.76B |
| Abbott Laboratories | 223.47B |
| AstraZeneca | 214.65B |
| Novartis AG | 211.71B |